Judith D. Auerbach, PhD*

Judith Auerbach is a public sociologist, independent science and policy consultant, and professor in the School of Medicine at the University of California, San Francisco (UCSF). She previously served as vice president, research and evaluation at the San Francisco AIDS Foundation, vice president, public policy and program development, at amfAR, director of the behavioral and social science program and HIV prevention science coordinator in the Office of AIDS Research at the U.S. National Institutes of Health (NIH), assistant director for social and behavioral sciences in the White House Office of Science and Technology Policy, and senior program officer at the Institute of Medicine.

Dr. Auerbach received her Ph.D. in Sociology from the University of California, Berkeley, and has taught, presented and published widely in the areas of HIV/AIDS, social science, public policy and sex and gender. Her articles have appeared in such journals as JAIDS, Health Affairs, Journal of the International AIDS Society, Journal of Health and Social Behavior, AIDS Patient Care and STDs, Clinical Infectious Diseases, and Global Public Health. Dr. Auerbach has served on numerous professional and advisory groups, including, currently, the U.S. National Advisory Council on Drug Abuse, PEPFAR Scientific Advisory Board, Governing Council of the International AIDS Society, IAVI ADVANCE Scientific Advisory Group, and Board of Directors of The Well Project, among others.

For her science and policy work, Dr. Auerbach has received numerous awards including the 2006 Research in Action Award from the Treatment Action Group (TAG), the 2008 Career Award from the Sociologists AIDS Network, the 2010 Thomas M. Kelly Leadership Award from Project Inform, and the 2014 Feminist-Scholar-Activist Award from the Sex and Gender Section of the American Sociological Association.

*member of the WRI advisory board

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

none_existing name
Tue, 11/30/2021 - 1:34am

Red40something's picture

Red40something liked the aglm_blog Thanks-Giving

Tue, 11/30/2021 - 1:32am
Mon, 11/29/2021 - 6:07pm

Get basic information about a variety of approaches to treating the metabolic changes that may result from living with HIV or taking HIV drugs.

Lipodystrophy means abnormal fat changes. This article addresses treatments for fat loss, or lipoatrophy.

Get basic information about lipodystrophy: body shape changes, metabolic complications, and causes and treatment of fat loss and fat gain.